Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolphe Thiebaut

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Plos One|February 4, 2014
An evaluation of HIV elite controller definitions within a large seroconverter cohort collaborationAshley D Olson, Laurence Meyer, Maria Prins, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
The Lancet. HIV|October 2, 2015
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort studyNikos Pantazis, Kholoud Porter, Dominique Costagliola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Plos Medicine|November 9, 2013
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling studyMarie-Quitterie Picat, Joanna Lewis, Victor Musiime, et al.
Plos One|August 13, 2013
Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaborationGiota Touloumi, Nikos Pantazis, Marie-Laure Chaix, et al.
Plos One|April 9, 2020
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individualsMathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2010
CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007Mathias Bruyand, Marie-Anne Vandenhende, Guillaume Marcel, et al.
AIDS (London, England)|November 7, 2015
Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patientsPierre Duffau, Linda Wittkop, Estibaliz Lazaro, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Plos One|February 4, 2014
An evaluation of HIV elite controller definitions within a large seroconverter cohort collaborationAshley D Olson, Laurence Meyer, Maria Prins, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
The Lancet. HIV|October 2, 2015
Temporal trends in prognostic markers of HIV-1 virulence and transmissibility: an observational cohort studyNikos Pantazis, Kholoud Porter, Dominique Costagliola, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Influence of the Antiretroviral Regimen on the Early Changes in Plasma HIV RNA and Immune Activation at Initiation of Antiretroviral Therapy in Naïve HIV-1-Infected PatientsAssia Samri, Mathieu Chalouni, Julià Blanco, et al.
Plos Medicine|November 9, 2013
Predicting patterns of long-term CD4 reconstitution in HIV-infected children starting antiretroviral therapy in sub-Saharan Africa: a cohort-based modelling studyMarie-Quitterie Picat, Joanna Lewis, Victor Musiime, et al.
Plos One|August 13, 2013
Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaborationGiota Touloumi, Nikos Pantazis, Marie-Laure Chaix, et al.
Plos One|April 9, 2020
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individualsMathieu Chalouni, Javier Rodriguez-Centeno, Assia Samri, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 4, 2010
CMV plasma DNAemia and risk of cancer among HIV-infected patients: a case-control study nested in the ANRS CO3 Aquitaine Cohort, France, 2002-2007Mathias Bruyand, Marie-Anne Vandenhende, Guillaume Marcel, et al.
AIDS (London, England)|November 7, 2015
Association of immune-activation and senescence markers with non-AIDS-defining comorbidities in HIV-suppressed patientsPierre Duffau, Linda Wittkop, Estibaliz Lazaro, et al.
Diabetes Care|December 6, 2008
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) studySigne W Worm, Caroline A Sabin, Peter Reiss, et al.
Pageof 6